Financial Year End | 2022-12-31 | 2021-08-31 | 2020-08-31 | 2019-08-31 | 2018-08-31 | 2017-08-31 | 2016-08-31 | 2015-08-31 | 2014-08-31 |
---|---|---|---|---|---|---|---|---|---|
Revenue | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Cost of Revenue | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Gross Profit | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Operating Expenses | 10.29M | 7.44M | 4.69M | 3.21M | 2.34M | 232.79K | 15.24K | 15.27K | 15.27K |
Selling, General & Admin | 5.96M | 4.60M | 2.77M | 2.12M | 1.09M | 232.79K | 509.00 | 4.27K | N/A |
Research & Development | 4.32M | 2.84M | 1.92M | 1.09M | 1.25M | N/A | N/A | N/A | N/A |
Other Operating Expenses | N/A | N/A | 1.41K | 31.26K | 290.00 | N/A | 14.73K | 11.00K | 15.27K |
Operating Income | -10.29M | -7.44M | -4.69M | -3.21M | -2.34M | -232.79K | -15.24K | -15.27K | -15.27K |
Other Expenses / Income | 204.00K | 2.00K | 30.91K | 1.04M | N/A | -2.10K | N/A | N/A | N/A |
Before Tax Income | -10.08M | -7.44M | -4.65M | -2.17M | -2.34M | -234.89K | -15.24K | -15.27K | -15.27K |
Income Tax Expenses | -209.00K | -4.00K | -60.41K | -2.04M | 8.00 | N/A | N/A | N/A | N/A |
Net Income | -9.87M | -7.44M | -4.65M | -2.17M | -2.34M | -234.89K | -15.24K | -15.27K | -15.27K |
Interest Expenses | 5.00K | N/A | N/A | N/A | N/A | 2.10K | N/A | N/A | N/A |
Basic Shares Outstanding | 2.83M | 1.25M | 247.00K | 144.00K | 84.00K | N/A | 6.41M | 3.07M | 3.07M |
Diluted Shares Outstanding | 2.83M | 1.25M | 247.18K | 144.83K | 85.17K | N/A | 6.41M | 3.07M | 3.07M |
EBITDA | -10.29M | -7.44M | -4.71M | -4.22M | -2.34M | -232.79K | -15.24K | -15.27K | -15.27K |
EBITDA Margin | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
EBIT | -10.08M | -7.44M | -4.72M | -4.22M | -2.34M | -232.79K | -15.24K | -15.27K | -15.27K |
EBIT Margin | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Financial Year End | 2022-12-31 | 2021-08-31 | 2020-08-31 | 2019-08-31 | 2018-08-31 | 2017-08-31 | 2016-08-31 | 2015-08-31 | 2014-08-31 |